Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study was a single-arm trial to obtain preliminary data on the efficacy of collagen
membranes impregnated with recombinant human fibroblast growth factor (rhFGF-2) in the
treatment of Miller's class I and class II gingival recessions.